XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   58,504,000        
Beginning balance at Dec. 31, 2021 $ 1,310,736 $ 5,850 $ 963,851 $ 358,598 $ (10,569) $ (6,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) (63,195)     53,343   (116,538)
Stock based compensation expense 4,116   4,116      
Common stock transactions related to stock based employee benefit plans (in shares)   176,000        
Common stock transactions related to stock based employee benefit plans (1,081) $ 18 (36)   (1,063)  
Common stock issued for stock options (in shares)   180,000        
Common stock issued for stock options 3,442 $ 18 3,424      
Issuance of common stock, pursuant to acquisitions (in shares)   2,550,000        
Issuance of common stock, pursuant to acquisitions 90,234 $ 255 89,979      
Conversion of options, pursuant to acquisition 3,833   3,833      
Dividends on common stock (18,510)     (18,510)    
Increase (decrease) in shares during period (in shares)   2,906,000        
Increase (decrease) in stockholders' equity during period 18,839 $ 291 101,316 34,833 (1,063) (116,538)
Ending balance (in shares) at Jun. 30, 2022   61,410,000        
Ending balance at Jun. 30, 2022 1,329,575 $ 6,141 1,065,167 393,431 (11,632) (123,532)
Beginning balance (in shares) at Mar. 31, 2022   61,239,000        
Beginning balance at Mar. 31, 2022 1,356,285 $ 6,124 1,062,462 371,192 (10,459) (73,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) (17,743)     32,755   (50,498)
Stock based compensation expense 2,697   2,697      
Common stock transactions related to stock based employee benefit plans (in shares)   169,000        
Common stock transactions related to stock based employee benefit plans (1,187) $ 17 (31)   (1,173)  
Common stock issued for stock options (in shares)   2,000        
Common stock issued for stock options 39   39      
Dividends on common stock (10,516)     (10,516)    
Increase (decrease) in shares during period (in shares)   171,000        
Increase (decrease) in stockholders' equity during period (26,710) $ 17 2,705 22,239 (1,173) (50,498)
Ending balance (in shares) at Jun. 30, 2022   61,410,000        
Ending balance at Jun. 30, 2022 $ 1,329,575 $ 6,141 1,065,167 393,431 (11,632) (123,532)
Beginning balance (in shares) at Dec. 31, 2022 71,617,852 71,618,000        
Beginning balance at Dec. 31, 2022 $ 1,607,775 $ 7,162 1,377,802 423,863 (13,019) (188,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 44,285     43,076   1,209
Stock based compensation expense 7,096   7,096      
Common stock transactions related to stock based employee benefit plans (in shares)   448,000        
Common stock transactions related to stock based employee benefit plans (1,309) $ 46 (203)   (1,152)  
Common stock issued for stock options (in shares)   231,000        
Common stock issued for stock options 5,040 $ 22 5,018      
Repurchase of common stock (in shares)   (3,000)        
Repurchase of common stock (45)   (45)      
Issuance of common stock, pursuant to acquisitions (in shares)   12,792,000        
Issuance of common stock, pursuant to acquisitions 410,738 $ 1,279 409,459      
Conversion of options, pursuant to acquisition 10,304   10,304      
Dividends on common stock (29,852)     (29,852)    
Increase (decrease) in shares during period (in shares)   13,468,000        
Increase (decrease) in stockholders' equity during period $ 446,257 $ 1,347 431,629 13,224 (1,152) 1,209
Ending balance (in shares) at Jun. 30, 2023 85,086,269 85,086,000        
Ending balance at Jun. 30, 2023 $ 2,054,032 $ 8,509 1,809,431 437,087 (14,171) (186,824)
Beginning balance (in shares) at Mar. 31, 2023   84,609,000        
Beginning balance at Mar. 31, 2023 2,051,084 $ 8,461 1,803,898 421,271 (13,113) (169,433)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income (loss) 13,858     31,249   (17,391)
Stock based compensation expense 4,454   4,454      
Common stock transactions related to stock based employee benefit plans (in shares)   377,000        
Common stock transactions related to stock based employee benefit plans (1,144) $ 38 (124)   (1,058)  
Common stock issued for stock options (in shares)   103,000        
Common stock issued for stock options 1,258 $ 10 1,248      
Repurchase of common stock (in shares)   (3,000)        
Repurchase of common stock (45)   (45)      
Dividends on common stock (15,433)     (15,433)    
Increase (decrease) in shares during period (in shares)   477,000        
Increase (decrease) in stockholders' equity during period $ 2,948 $ 48 5,533 15,816 (1,058) (17,391)
Ending balance (in shares) at Jun. 30, 2023 85,086,269 85,086,000        
Ending balance at Jun. 30, 2023 $ 2,054,032 $ 8,509 $ 1,809,431 $ 437,087 $ (14,171) $ (186,824)